InvestorsHub Logo
Followers 122
Posts 17458
Boards Moderated 0
Alias Born 01/06/2014

Re: None

Tuesday, 06/08/2021 5:13:01 PM

Tuesday, June 08, 2021 5:13:01 PM

Post# of 430307
Member of FDA’s expert panel resigns over controversial Alzheimer’s therapy approval.

10 of the 11 panelists found that there was not enough evidence to show it could slow cognitive decline. The 11th voted “uncertain.”

This was the first time that nobody voted for approval of this drug — nobody — and they went against that.”

https://www.statnews.com/2021/06/08/fda-expert-panel-resigns-alzheimers-approval/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News